Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis

Mariano Provencio, Mark M. Awad, Jonathan D. Spicer, Annelies Janssens, Fedor Moiseyenko, Yang Gao, Yasutaka Watanabe, Aurelia Alexandru, Florian Guisier, Nikolaj Frost, Fabio Franke, T. Jeroen Nicolaas Hiltermann, Jie He, Fumihiro Tanaka, Shun Lu, Cinthya Coronado Erdmann, Padma Sathyanarayana, Phuong Tran, Vipul Devas, Tina Cascone

Open source

DOI: 10.1038/s43018-025-01104-z
Published: 2026-01-08
Container: Nature Cancer
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s43018-025-01104-z,
  title = {Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis},
  author = {Mariano Provencio and Mark M. Awad and Jonathan D. Spicer and Annelies Janssens and Fedor Moiseyenko and Yang Gao and Yasutaka Watanabe and Aurelia Alexandru and Florian Guisier and Nikolaj Frost and Fabio Franke and T. Jeroen Nicolaas Hiltermann and Jie He and Fumihiro Tanaka and Shun Lu and Cinthya Coronado Erdmann and Padma Sathyanarayana and Phuong Tran and Vipul Devas and Tina Cascone},
  year = {2026},
  journal = {Nature Cancer},
  doi = {10.1038/s43018-025-01104-z},
  url = {https://doi.org/10.1038/s43018-025-01104-z}
}

RIS

TY  - JOUR
TI  - Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis
AU  - Mariano Provencio
AU  - Mark M. Awad
AU  - Jonathan D. Spicer
AU  - Annelies Janssens
AU  - Fedor Moiseyenko
AU  - Yang Gao
AU  - Yasutaka Watanabe
AU  - Aurelia Alexandru
AU  - Florian Guisier
AU  - Nikolaj Frost
AU  - Fabio Franke
AU  - T. Jeroen Nicolaas Hiltermann
AU  - Jie He
AU  - Fumihiro Tanaka
AU  - Shun Lu
AU  - Cinthya Coronado Erdmann
AU  - Padma Sathyanarayana
AU  - Phuong Tran
AU  - Vipul Devas
AU  - Tina Cascone
PY  - 2026
JO  - Nature Cancer
DO  - 10.1038/s43018-025-01104-z
UR  - https://doi.org/10.1038/s43018-025-01104-z
ER  -

APA

Provencio, M., Awad, M. M., Spicer, J. D., Janssens, A., Moiseyenko, F., Gao, Y., Watanabe, Y., Alexandru, A., Guisier, F., Frost, N., Franke, F., Hiltermann, T. J. N., He, J., Tanaka, F., Lu, S., Erdmann, C. C., Sathyanarayana, P., Tran, P., Devas, V., & Cascone, T. (2026). Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis. Nature Cancer. https://doi.org/10.1038/s43018-025-01104-z

Source records

crossref · retrieved 2026-09-26T11:29:28.922Z